Overview

Extension Study of Patients Successfully Treated by Ziprasidone in Study A1281031

Status:
Completed
Trial end date:
2008-10-01
Target enrollment:
Participant gender:
Summary
Open label extension study of Ziprasidone, evaluation of safety of long term use of ziprasidone
Phase:
Phase 3
Details
Lead Sponsor:
Pfizer
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Treatments:
Ziprasidone